A systematic review of the prevalence of anxiety symptoms during coronavirus epidemics.
J Health Psychol
; 26(1): 115-125, 2021 01.
Article
in English
| MEDLINE | ID: covidwho-1064203
ABSTRACT
Coronavirus pandemics causes systemic and mainly pulmonary changes. We assessed the prevalence of generalized anxiety disorder (GAD) in pandemic survivors and the general population. Papers indexed by MEDLINE/PubMed, The Cochrane, Embase, Lilacs, Scielo, Psycoinfo, and Pepsic databases were searched to April 2020, using GAD and Coronavirus (CoV) infection as keywords. Sixteen studies with 25,779 participants in eight countries were included. A 46% pooled prevalence of anxiety symptoms (95% CI 33.9-58.2%) was found with significant evidence of between-study heterogeneity (Q = 154953, I2 = 99.99%, p < 0.001). Age and sex were not found to be significant moderators for anxiety symptoms. Intervention programs for anxiety symptoms are highly recommended.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Anxiety Disorders
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Reviews
/
Systematic review/Meta Analysis
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
J Health Psychol
Journal subject:
Psychology
Year:
2021
Document Type:
Article
Affiliation country:
1359105320951620
Similar
MEDLINE
...
LILACS
LIS